Renal cell carcinoma (RCC) with rhabdoid features is a rare subtype of RCC. We describe the case of a 36-year-old man who presented with neck pain, and MRI which showed two infiltrative masses in the vertebral bodies. An abdominal CT demonstrated a heterogeneous mildly enhancing mass in the superior pole of the right kidney with internal necrosis. A chest CT revealed multiple enlarged hilar lymph nodes. EBUSguided FNA was performed. The smears and cell block material showed loose clusters and single neoplastic cells with large vesicular nuclei and prominent nucleoli and abundant eosinophilic cytoplasm with fine vacuoles and granules. The tumor cells were positive for CAM 5.2, P53, EMA (Focally positive), and negative for RCC and CD 10 by IHC and positive for the VHL W117fs mutation by Sanger sequencing. These results were consistent with the diagnosis of RCC with rhabdoid features, which is consistent with surgical diagnosis. To our knowledge, this is the first report of RCC with rhabdoid features diagnosed by endobronchial ultrasound-guided fine needle aspiration (EBUSguided FNA).
Introduction
Renal cell carcinoma (RCC) with rhabdoid features is a rare tumor which accounts for 3-5% of primary RCC (9). Sarcomatoid transformation is most common in clear cell RCC, but it can also be involved in other renal tumors, such as papillary RCC, collecting duct carcinoma and chromophobe RCC (4). Rhabdoid features are seen in RCC with sarcomatoid transformation. However, definite relationship between rhabdoid features and sarcomatoid transformation remains unknown (15) . These rhabdoid features are characteristic of a high histologic grade and pathological stage of RCC, and usually associated with aggressive behavior and poor prognosis (9, 27). The mean age at presentation is 60-years-old. Clinically, most patients present with an abdominal mass, hematuria or abdominal pain (9). In Leroy's study, 9 of 14 cases of renal cell carcinoma with rhabdoid features were staged pT3, all rhabdoid foci were classified as nuclear grade 4, and the median of survival was eight months (15) .
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The rhabdoid components are characterized by sheets of large discohesive epithelioid cells, eccentric nuclei, eosinophilic cytoplasmic inclusions, and prominent nucleoli. Recognizing these rhabdoid features is critical from a clinical standpoint, given their association with higher grade and stage of diseases.
These rhabdoid features are not only seen in kidney tumors, but also in primary tumors of other organs and systems including lung, thyroid gland, soft tissue, gastrointestinal system, genitourinary system, and central nervous system (1, 11, 13, 15, 22, 28) . It is critical to distinguish RCC with rhabdoid features from other types of cancers with similar cytomorphology. This distinction is important as management and prognostic significance are different. Endobronchial ultrasoundguided fine needle aspiration (EBUS-FNA) is an effective method in obtaining diagnostic tissues for the pathologic diagnosis. EBUS-FNA can evaluate organs within the mediastinum or abdominal cavity, as well as small focal lesions. It not only differentiates between malignant and non-malignant lesions, but also between the various tumors from different origins (24) . More importantly, EUBS-FNA is an important tool for the diagnosis of primary and metastatic RCC (16, 20) . We report a case with atypical presentation of RCC with rhabdoid features, which was diagnosed by EBUS-FNA and confirmed by immunohistochemistry.
Case Report
A 36-year-old previously healthy male patient presented with neck pain and numbness radiating to the posterior side of his left arm and shoulder, and left fingers. Muscle relaxants or steroids could not relieve the symptoms. MRI performed elsewhere showed a C-spine mass with a fracture. Physical examination showed no abrasions, ecchymosis, laceration, or deformity of spine. Spurling's test was positive reproduced left arm numbness and tingling. The patient was a nonsmoker without significant medical and family history. An abdominal CT demonstrated a 7.2 ×5.3 ×4.8 cm heterogeneous mildly enhancing mass in the superior pole of the right kidney with internal necrosis. Chest CT demonstrated lymphadenopathy of the right hilum and an aortocaval lymph node, which might represent nodal involvement. Contrast enhanced MRI showed two metastatic infiltrative masses in the C6 vertebral body ( Figure 1A -C). A destructive soft tissue mass occupying the anterior and posterior T4 vertebral body showed heterogeneous enhancement. EBUS-guided FNA procedure was performed under monitored anesthesia. Cytology samples were obtained during EBUS-guided FNA using 22-gauge needle. The specimen was expressed on the slides, stained with Diff-Quik, Papanicolaou-stained smears and H&Estained cellblock preparations were made for evaluation and diagnosis. The biopsy specimens were attained by ultrasound guided evaluation of right cervical lymph nodes, and fixed in 10% formalin, embedded in paraffin and stained with hematoxylin-eosin.
Immunohistochemistry
Immunohistochemical staining was performed with markers as follows: P53, CAM5.2, EMA, RCC and CD 10.
Sanger Sequencing
DNA extraction: Genomic DNA was extracted from paraffin-embedded tissues from the C6 vertebral lesion biopsy using the Maxwell CSC DNA FFPE Kit in combination with the Maxwell CSC Instrument (Promega, Madison, WI). DNA quality and quantity were measured by using Nanodrop (Thermo Fisher Scientific, Wilmington, DE). Primers for all exons flanked the respective intron/exon junctions. Direct sequence analysis of PCR products was performed in both forward and reverse directions using automated fluorescence dideoxy sequencing methods. Reference sequences NM_000551.2 and NT_022517.17 were used for sequence comparison. The nomenclature was based on the convention recommended by the Human Genome Variation Society (http://www.hgvs.org/mutnomen/). 
Results

Discussion
FNA is a commonly used approach to rule in or out a metastasis in patients presenting with tumors of unknown primary (20) . The most common organs of primary tumors are lung, melanoma and kidney (20) , though broader differential diagnosis should be kept in mind. RCC with rhabdoid features is a rare entity. The incidence of RCC with rhabdoid features ranges from 3.1% to 7.4% (9). To the best of our knowledge, metastatic RCC with rhabdoid features diagnosed by EBUS-FNA has not been previously reported. Cytomorphology of RCC with rhabdoid features includes discohesive tumor cells with eccentric nuclei, eosinophilic cytoplasmic inclusions, and prominent nucleoli, which are defined features of rhabdoid cells. The differential diagnosis is broad, because neoplasms with rhabdoid features include primary adenocarcinomas from the gastrointestinal system, genitourinary system, respiratory system, central nervous system, and malignant melanoma (2, 3, 17, 26) . In addition, some soft tissue neoplasms such as epithelioid sarcomas and synovial sarcoma also have rhabdoid features (19, 25) . In this case, the cytological features were highly suggestive of metastasis from the renal neoplasm when combined with imaging studies and clinical history. Recognizing these features is crucial in patient care as it can avoid unnecessary surgical procedures for patients with advanced diseases.
The cytomorphology varies according to different subtype of RCC, and the most common type of RCC is clear cell (conventional) RCC (16) . Tumor cells of this type are characterized by irregular nuclear contours, centrally located nuclei and prominent nucleoli with clear or granular cytoplasm. However, tumor cells of this case have rhabdoid features without typical cytoplasmic features of clear cell RCC. Since this patient is young, other subtypes of RCC, such as the recently described Xp11.2 translocation-associated RCC, were also considered. This subtype is commonly seen in the pediatric population and in young adults. The tumor cells can also have eccentrical nuclei, irregular nuclear contour with prominent nucleoli, but the cytoplasm is usually clear or granular, which is similar to clear cell RCC (29) .
Immunohistochemistry was also used to establish the diagnosis. We used P53, CAM5.2, EMA, RCC and CD 10. The tumor cells were positive for CAM 5.2, P53, EMA (focally positive), and negative for RCC and CD10 (figure). These results are suggestive of RCC with rhabdoid features, though these immunohistochemical stains are neither sensitive nor specific. More importantly, since the tissue for FNA is limited, the results of stains need to be interpreted with caution. After diagnosis was established by EUS-FNA, subsequent biopsy of the C6 vertebral lesion was obtained, and histopathology showed large discohesive tumor cells with eccentric nuclei, eosinophilic cytoplasmic inclusions, and prominent nucleoli. These histomorphological features were similar to those found in the EUS-FNA specimen. Additionally, the results of immunohistochemical stains showed the same results as those in the FNA specimen.
In addition to immunohistochemistry, sequencing studies are a useful ancillary tool to aid in diagnosis. The von Hippel-Lindau (VHL) gene is a tumor suppressor gene on chromosome 3p25 discovered in 1993. Inactivation of VHL gene contributes to von Hippel-Lindau tumor syndrome, which is characterized by multiple tumors including pheochromocytoma, clear cell renal cell carcinoma of the kidney, and vascular tumors including benign hemangioblastomas of the cerebellum, spine, brain stem and retina (8). Clear cell RCC is a common cause of death of patients with VHL (8).
The protein product of the VHL gene is a 35 kDa protein, which is part of a complex including elongin B, elongin C, Cul2 and Rbx1 (VCB-CUL2 complex) (5). The N-terminal beta-sheet domain of VHL binds substrates, and its C-terminal α-helical domain interacts with elongin B and elongin C (5, 23). Targets of the VCB-CUL2 complex include hypoxiainducible factor 2-alpha (HIF-2α), which stimulates other signaling pathways when oxygen levels are changed in the body. In the condition of hypoxia, HIF induces formation of angiogenesis by regulating production of erythropoietin, and vascular endothelial growth factor (VEGF), which is involved in tumorigenesis. More than 370 inherited mutations in the VHL gene have been reported in patients with Von Hipple-Lindau Syndrome, and somatic mutations in the VHL gene are associated with clear cell RCC(6). When the VHL gene is mutated, the VCB-CUL2 complex cannot degrade HIF-2α, and thus HIF can accumulate in the body. Consequently, it stimulates angiogenesis in non-hypoxia conditions such as tumorigenesis. On the other hand, VHL also functions in an HIFindependent way and plays a role in other cellular functions, such as secreting extracellular matrix components, regulating nuclear factor kappa B activity and maintaining microtubule stability (12, 14, 18, 30) . The tumor in our case showed a mosaic c.349del (p.W117fs) mutation. Interestingly, 35% to 75% of clear cell RCC with VHL mutations have been reported according to different studies (6); however, to our knowledge, the presence of VHL gene mutations in cases of RCC with rhabdoid features has been rarely reported (21) . Loss of heterozygosity at the VHL locus has been found in 98% of clear cell RCC cases (7, 10). On the contrary, other renal neoplasm such as clear cell papillary renal cancer or translocation carcinomas often lack VHL mutations (7).
The significance of a mutated VHL gene in RCC with rhabdoid features is unknown. However, mutations of the VHL gene have been reported to be related to tumor initiation and progression to metastasis in clear cell RCC, and be associated with poor prognosis (7).The patient was transferred to another hospital; the clinical outcome of this patient is unknown. However, a poor prognosis is expected based on pathological findings and the stage 4 disease.
Conclusion:
To our knowledge, this is the first case report of RCC with rhabdoid features diagnosed by EBUS-guided FNA. RCC with rhabdoid features should be considered in the differential diagnosis of an FNA specimen composed entirely of cells with rhabdoid morphology. Furthermore, it is the one of rare reports of VHL gene mutation in a patient with RCC with rhabdoid features. Mutations in VHL gene can be seen in RCC with rhabdoid features and may represent an adverse prognostic factor for these patients. 
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